Neoplasm
Therapeutic area
Oncology
Rare disease
No
- Definition
- A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Neoplasm
- Therapeutic area
- Oncology
- neoplasm
- Advanced Neoplasia
- Advanced Tumour Diseases
- disease of cellular proliferation
- Metastatic Neoplasia
- neoplasia
- neoplasm (disease)
- neoplastic disease
- neoplastic growth
- tumor
- tumor disease
- tumour
- tumour disease
- other neoplasm
- cell process disease
- All therapeutic areas
- Oncology
Sources for recorded values
- Severity
- Severe
- MONDO ID
- MONDO:0005070
- Parent condition
- MONDO:0023370
Related records
Broader conditions (5)
- Cancer or benign tumor
- Disease
- Disease by etiologic mechanism
- Human disease
- Neoplastic disease or syndrome
Narrower conditions (4,411)
- 22q-related schwannomatosis
- A53 diffuse large B-cell lymphoma
- Abdominal cystic lymphangioma
- Abducens nerve neoplasm
- Acanthokeratolytic verrucous nevus
- Acantholytic acanthoma
- Acantholytic squamous cell skin carcinoma
- Acantholytic variant squamous cell breast carcinoma
- Acanthoma
- Acinar cell carcinoma
- Acinar lung adenocarcinoma
- Acinar prostate adenocarcinoma, foamy gland variant
- Acinar prostate adenocarcinoma, signet ring variant
- Acinar prostate mucinous adenocarcinoma
- Acinic cell breast carcinoma
- Acoustic neuroma
- Acquired cystic disease-associated renal cell carcinoma
- Acquired elastotic haemangioma
- Acquired hemangioma
- Acquired polycythemia vera
Trials (17,132)
- : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors
- 'Lung Health Check' Biomarker Study
- " Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease"
- "ADEN Platform: Pilot Clinical Validation for Chronic Disease Risk Stratification in Colombia"
- "AFRONTA Emotional Care" Intervention for Family Caregivers of Children With Cancer.
- "Cancersensor" Chemotherapy
- "Cancersensor" Metastasis Resection
- "Cancersensor": Circadian Rhythms
- "Evaluation of a Non-Pharmacological Skin Care Intervention for the Prevention and Treatment of Skin Toxicities Caused by Immunotherapy in Cancer Patients"
- "Patient Autonomie" in People With Cancer
- "Prescribing" Exercise to Cancer Patients At High-Risk for Falls
- "Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
- "Walking Together with Love": a Couples-Based Intervention for Sexual and Relationship Distress in Cancer Patients
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- (Bispecific) Antibodies in Cancer Patients
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
- (Cost-)Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Cancer Patients
- (COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
- (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Approved drugs (321)
- Abarelix
- Abemaciclib
- Abiraterone
- Acalabrutinib
- Adagrasib
- Aflibercept
- Aldesleukin
- Alectinib
- Alitretinoin
- Alpelisib
- Altretamine
- Amifampridine
- Amifampridine phosphate
- Aminoglutethimide
- Aminolevulinic acid
- Amivantamab
- Amrubicin hydrochloride
- Amsacrine
- Anagrelide
- Anastrozole
Drugs in development (1,801)
- 13-deoxydoxorubicin Phase 1
- 2-methoxyestradiol Phase 1
- 2X-121 Phase 1
- 4-isothioureidobutyronitrile Phase 1
- 4'-thio-2'-deoxycytidine Phase 1
- 5-fluorouridine Phase 2
- 6-O-benzylguanine Phase 3
- 7-ethyl-10-hydroxycamptothecin Phase 1
- Abefolastat tesaroxetan Phase 2
- Abequolixron Phase 1
- Abequolixron zinc Phase 1
- Abexinostat Phase 1
- Abexinostat hydrochloride Phase 1
- Abipapogene suvaplasmid Phase 2
- ABM-1310 Phase 1
- ABT-510 Phase 1
- AC-480 Phase 1
- Acapatamab Phase 1
- Acasunlimab Phase 1
- Acetaminophen Phase 3
Other linked drugs (5)
- Abiraterone acetate
- Fosaprepitant dimeglumine
- Mirabegron
- Thyrotropin alfa
- Tositumomab